Fri, May 23, 2014
Thu, May 22, 2014
Wed, May 21, 2014
Tue, May 20, 2014
Mon, May 19, 2014
Fri, May 16, 2014
Thu, May 15, 2014
Wed, May 14, 2014
Tue, May 13, 2014
Mon, May 12, 2014

Matt Miksic Upgraded (ABT) to Buy on, May 19th, 2014

Matt Miksic of Credit Suisse, Upgraded "Abbott Laboratories" (ABT) to Buy on, May 19th, 2014.

Matt has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Thursday, January 23rd, 2014